Markets › Stocks › VANTABIO
VA

Vanta Bioscience Ltd

NSE: VANTABIO BSE: 540729Healthcare
Download Research Report7-page PDF
₹23.12
▲ +5.00%
NSE · auto-updates while market open
Mkt Cap
-
P / E
-
P / B
-
ROE
-
52W High
₹31.33
52W Low
₹14.71
Key Metrics
Market Cap
-
P / E
-
P / B
-
EV / EBITDA
-
ROCE
-
ROE
-
Debt / Equity
-
Book Value
-
EPS
₹0.15
Div Yield
0.0%
Face Value
₹10
Promoter Holding
72.8%
Revenue · ₹ Cr
14
FY20
10
FY21
10
FY22
6
FY23
10
FY24
2
FY25
2
FY26
Net Profit · ₹ Cr
0
FY20
0
FY21
0
FY22
0
FY23
0
FY24
0
FY25
0
FY26
EPS · ₹ per share
₹1.2
₹1.6
₹0.7
₹0.1
₹0.1
₹-10.3
₹-3.7
FY19FY20FY21FY22FY23FY24FY26
Cash Flow Trend · ₹ Cr
5
−12
FY22
−1
−1
FY23
3
3
FY24
−2
−9
FY25
−5
−12
FY26
Operating cash flowFree cash flow (CFO − capex)
Scorecard · 7 axes
Quality
-
Valuation
-
Growth
Bad
-17.1%
Profitability
-
Performance
Bad
-13.7%
Entry Point
Good
74%
Red Flags
Strong
0 flags
Shareholding Pattern
72.8%Promoter
Promoter72.8%
Public27.2%
AlertPre-trade